Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'

Omlin et al (2013) report the anti-tumour activity of diethylstilbestrol (DS) and abiraterone (AA) in castration-resistant prostate cancer and suggest substantial activity of AA in DS pretreated patients. Their retrospective review includes patients who were post docetaxel as well as those who were chemotherapy naive. We feel that the additional activity of… CONTINUE READING